Paclitaxel (Taxol) is one of the most active drugs in the treatment of ovarian and breast cancers. Combination therapy with paclitaxel and 5-fluorouracil (5-FU) exhibits high activity in anthracycline-pretreated breast cancer,
J. Dethling, MD
Advertisement
Articles by J. Dethling, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Sacituzumab Govitecan Receives FDA Approval Across 2 TNBC Indications
2
FDA Approves Palbociclib Combo in HR+, HER2+ Metastatic Breast Cancer
3
EU Approves Enfortumab Vedotin/Pembrolizumab in Cisplatin-Ineligible MIBC
4
Offering Hope and Support Towards The Cancer Survivorship Journey
5